Impact of MayoExpertAdvisor on Provider Adherence

Heart Failure Clinical Trial

— MEA Research  

Official title:

Impact of MayoExpertAdvisor (MEA) on Provider Adherence to Guideline Recommended Treatment for Hyperlipidemia, Atrial Fibrillation, and Heart Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02742545
• Other study ID #: 15-008444
• Status: Completed
• Phase: N/A
• Start date: April 2016
• Est. completion date: November 2016

Study information

• Verified date: April 2019
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the efficacy of MayoExpertAdvisor (MEA), a knowledge delivery tool, to improve adherence to best practices for patients with hyperlipidemia, atrial fibrillation and heart failure. Half of the clinicians will receive MEA, while the other half will not receive MEA.

The investigators hypothesize care teams with access to MEA will act upon recommendations at a higher rate than those care teams in the standard of care arm without access to MEA.

Description:

MEA is designed to increase adherence to consensus national guidelines and quality measures which are the standard of care for hyperlipidemia, atrial fibrillation, and heart failure. These diseases were selected based on national data which suggest there is less than optimal adherence to standard of care therapy and this non-adherence is associated with adverse cardiovascular outcomes.

There are 29 care teams in the Employee and Community Health (ECH) practice. Care teams are comprised of 4-8 clinicians who provide primary care to between 3,000 and 8000 patients. 8 care teams are resident/fellow led and will be excluded from the study. The remaining 21 care teams in the ECH practice will be stratified by clinic location and provider specialty (Internal Medicine, Family Medicine). 20 care teams will then be cluster-randomized to either the intervention arm or standard of care arm.

Prior to randomization, clinicians in both arms will receive the same educational module to the current guidelines for management of the atrial fibrillation, heart failure and hyperlipidemia. Clinicians in the intervention arm will receive training by the research team on the use of MEA. This training will clearly inform clinicians that they are always to use their best clinical judgment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2248
• Est. completion date: November 2016
• Est. primary completion date: November 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Clinician Inclusion Criteria:

• Physicians

• Assistants

• Nurse Practitioners

Clinician Exclusion Criteria:

• Clinicians providing care to nursing home patients

• Pediatricians

• Residents and fellows

Patient Record Inclusion Criteria:

• Diagnosis of hyperlipidemia, atrial fibrillation, and/or heart failure

Patient Record Exclusion Criteria:

• Unscheduled visits

Related Conditions & MeSH terms

• Atrial Fibrillation
• Heart Failure
• Hyperlipidemia
• Hyperlipidemias
• Hyperlipoproteinemias

Intervention

Behavioral:
• MayoExpertAdvisor
Access to MayoExpertAdvisor (MEA) in the electronic medical record (EMR). MEA will provide patient-specific knowledge and treatment suggestions for patients with hyperlipidemia, atrial fibrillation, and/or heart failure via a clickable tab in the Mayo Clinic EMR.

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of pre-visit recommendations for hyperlipidemia acted upon by providers		Baseline to 6 months
Primary	Percentage of pre-visit recommendations for atrial fibrillation acted upon by providers		Baseline to 6 months
Primary	Percentage of pre-visit recommendations for heart failure acted upon by providers		Baseline to 6 months

External Links

•   Mayo Clinic Clinical Trials